Intelligence · Clinical Development
Pipeline search results
Programs matching “methotrexate” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 23 pipeline programs matching "methotrexate" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
ADX-2191 (intravitreal methotrexate 0.8%)
Aldeyra Therapeutics
Proliferative Vitreoretinopathy
1 trial -
IAE0972+ Methotrexate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NPC
1 trial -
Infliximab + methotrexate (IFX + MTX)
Universal Integrated
Arthritis, Psoriatic
1 trial -
METHOTREXATE for Immune system disorders
Pari Pharma GmbH
Immune system disorders
1 trial -
methotrexate
Ultragenyx UK Limited
Liver Cirrhosis, Biliary
1 trial -
Methotrexate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Central Nervous System Lymphoma
1 trial -
Methotrexate tablets
The First People's Hospital of Lianyungang
Solid Tumors
1 trial -
TAK-715 and methotrexate
Takeda
Arthritis, Rheumatoid
1 trial -
TAK-783 and methotrexate
Takeda
Arthritis, Rheumatoid
1 trial -
Thalidomide and methotrexate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
T-LGL Leukemia
1 trial -
Methotrexate
Sana Biotechnology
Chronic Plaque Psoriasis
1 trial -
Methotrexate - Amneal
Amneal Pharma Europe Ltd
Psoriasis
1 trial -
Methotrexate PK (in combination with Novobiocin) in RA patients
Lacuna Pharma Pty Ltd
Rheumatoid arthritis
1 trial -
Etanercept , Methotrexate
Wyeth is now a wholly owned subsidiary of Pfizer
Rheumatoid Arthritis
1 trial -
Methotrexate
United Therapeutics Europe Ltd
Psoriatic Arthritis
1 trial -
Methotrexate plus sulfasalazine
Hospital Authority, Hong Kong
Rheumatoid Arthritis
1 trial -
Tofacitinib with methotrexate
Pfizer
Rhematoid Arthritis
1 trial -
methotrexate (MTX)
AbbVie
Psoriatic Arthritis
1 trial -
Methotrexate
Chinese University of Hong Kong
Rheumatoid Arthritis
1 trial -
Methotrexate
The First People's Hospital of Lianyungang
Knee Osteoarthritis
1 trial -
PCNSL-RMTEA
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Ruxolitinib+Calcineurin inhibitor+Methotrexate
The First People's Hospital of Lianyungang
Graft Versus Host Disease
1 trial -
methotrexate
Universal Integrated
Rheumatoid Arthritis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.